Patents by Inventor Tom Han Jin

Tom Han Jin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable, Spray Dryed, Immunogenic, Viral Compositions
    Publication number: 20180161415
    Abstract: Viruses, and particularly genetically engineered, replication deficient viruses such as adenoviruses, poxviruses, MVA viruses, and baculoviruses which encode one or more antigens of interest, such as TB, malarial, and HIV antigens, are spray dried with a mannitol-cyclodextrin-trehalose-dextran (MCTD) to form a powder where the viability of the viruses are maintained at a suitable level for mass vaccinations after spray drying, and where the viability of the viruses are maintained at suitable level over a period of storage time, even in the presence of humidity.
    Type: Application
    Filed: February 22, 2017
    Publication date: June 14, 2018
    Inventors: Tom Han Jin, Eric I-Fu Tsao
  • Stable, Spray Dryed, Immunogenic, Viral Compositions
    Publication number: 20180015158
    Abstract: Viruses, and particularly genetically engineered, replication deficient viruses such as adenoviruses, poxviruses, MVA viruses, and baculoviruses which encode one or more antigens of interest, such as TB, malarial, and HIV antigens, are spray dried with a mannitol-cyclodextrin-trehalose-dextran (MCTD) to form a powder where the viability of the viruses are maintained at a suitable level for mass vaccinations after spray drying, and where the viability of the viruses are maintained at suitable level over a period of storage time, even in the presence of humidity.
    Type: Application
    Filed: February 22, 2017
    Publication date: January 18, 2018
    Inventors: Tom Han Jin, Eric I-Fu Tsao
  • Stable, spray dryed, immunogenic, viral compositions
    Patent number: 9610343
    Abstract: Viruses, and particularly genetically engineered, replication deficient viruses such as adenoviruses, poxviruses, MVA viruses, and baculoviruses which encode one or more antigens of interest, such as TB, malarial, and HIV antigens, are spray dried with a mannitol-cyclodextrin-trehalose-dextran (MCTD) to form a powder where the viability of the viruses are maintained at a suitable level for mass vaccinations after spray drying, and where the viability of the viruses are maintained at suitable level over a period of storage time, even in the presence of humidity.
    Type: Grant
    Filed: May 20, 2010
    Date of Patent: April 4, 2017
    Assignee: Aeras Global TB Vaccine Foundation
    Inventors: Tom Han Jin, Eric I-Fu Tsao
  • STABLE, SPRAY DRYED, IMMUNOGENIC, VIRAL COMPOSITIONS
    Publication number: 20120058162
    Abstract: Viruses, and particularly genetically engineered, replication deficient viruses such as adenoviruses, poxviruses, MVA viruses, and baculoviruses which encode one or more antigens of interest, such as TB, malarial, and HIV antigens, are spray dried with a mannitol-cyclodextrin-trehalose-dextran (MCTD) to form a powder where the viability of the viruses are maintained at a suitable level for mass vaccinations after spray drying, and where the viability of the viruses are maintained at suitable level over a period of storage time, even in the presence of humidity.
    Type: Application
    Filed: May 20, 2010
    Publication date: March 8, 2012
    Inventors: Tom Han Jin, Eric I-Fu Tsao